首页 > 最新文献

Nepalese Journal of Ophthalmology最新文献

英文 中文
Barriers of Retinopathy of Prematurity Care in Nepal. 尼泊尔早产儿视网膜病变护理的障碍。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.76994
Eli Pradhan, Priya Bajgain, Manisha Shrestha, Aeesha Nj Mallik
{"title":"Barriers of Retinopathy of Prematurity Care in Nepal.","authors":"Eli Pradhan, Priya Bajgain, Manisha Shrestha, Aeesha Nj Mallik","doi":"10.3126/nepjoph.v16i1.76994","DOIUrl":"10.3126/nepjoph.v16i1.76994","url":null,"abstract":"","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"1-4"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scleral Necrosis in a Case of Seasonal Hyperacute Panuveitis Successfully Treated with Amniotic Membrane Graft: A Case Report. 羊膜移植成功治疗季节性超急性全葡萄膜炎巩膜坏死1例。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.59410
Eliya Shrestha, Hara Maya Gurung, Babita Gurung, Hari Bikram Adhikari, Krishna Gurung, Anju Gurung

Introduction: Seasonal hyperacute panuveitis (SHAPU) is still a dilemma in the field of ophthalmology. Every alternate odd year from September until January, children usually present with unilateral painless red eyes if not treated in a timely manner, rapidly progressing to phthisis bulbi.

Case: Case was also diagnosed as a case of seasonal hyperacute panuveitis.

Observations: However, during the treatment, the patient developed spontaneous scleral necrosis, which has not been reported to date.

Conclusion: Seasonal hyperacute panuveitis may have different clinical presentation, therefore cases of seasonal hyperacute panuveitis should be monitored and evaluated properly before initiating treatment.

简介:季节性超急性全葡萄膜炎(SHAPU)仍然是眼科领域的一个难题。每隔一年9月至次年1月,患儿通常表现为单侧无痛性红眼,如不及时治疗,可迅速发展为球性肺结核。病例:病例同时被诊断为季节性超急性全葡萄膜炎。观察:然而,在治疗过程中,患者出现自发性巩膜坏死,迄今未见报道。结论:季节性超急性全葡萄膜炎可能有不同的临床表现,因此在开始治疗前应进行适当的监测和评估。
{"title":"Scleral Necrosis in a Case of Seasonal Hyperacute Panuveitis Successfully Treated with Amniotic Membrane Graft: A Case Report.","authors":"Eliya Shrestha, Hara Maya Gurung, Babita Gurung, Hari Bikram Adhikari, Krishna Gurung, Anju Gurung","doi":"10.3126/nepjoph.v16i1.59410","DOIUrl":"10.3126/nepjoph.v16i1.59410","url":null,"abstract":"<p><strong>Introduction: </strong>Seasonal hyperacute panuveitis (SHAPU) is still a dilemma in the field of ophthalmology. Every alternate odd year from September until January, children usually present with unilateral painless red eyes if not treated in a timely manner, rapidly progressing to phthisis bulbi.</p><p><strong>Case: </strong>Case was also diagnosed as a case of seasonal hyperacute panuveitis.</p><p><strong>Observations: </strong>However, during the treatment, the patient developed spontaneous scleral necrosis, which has not been reported to date.</p><p><strong>Conclusion: </strong>Seasonal hyperacute panuveitis may have different clinical presentation, therefore cases of seasonal hyperacute panuveitis should be monitored and evaluated properly before initiating treatment.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"94-97"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Profile and Treatment Outcomes of Acute Retinal Necrosis in a Tertiary Eye Care Centre in Nepal. 尼泊尔三级眼科护理中心急性视网膜坏死的临床概况和治疗结果。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.62167
Priyanka Shrestha, Anu Manandhar

Introduction: Acute retinal necrosis (ARN) is a rapidly progressive, necrotizing herpetic infection, commonly leading to retinal detachment with significant visual morbidity. Most common causative agent belong to the herpesvirus family. It commonly occurs in healthy immunocompetent individuals. Early diagnosis of disease is important in order to start the treatment timely. Systemic antivirals and intravitreal antiviral therapy along with steroids are the main stay of treatment. Our study is a retrospective study of 5 years. We studied the patient demographics, presenting features, treatment outcome and complications of acute retinal necrosis in a tertiary care center in Nepal.

Objective: Methodology: A total of 14 eyes of 13 patients were included in the study. This study is a hospital based retrospective study done in the Uveitis and Vitreoretinal department of a tertiary eye care center. Records of all patients diagnosed with Acute Retinal Necrosis between May 2013 to May 2018 were included in this study. Hospital data of these subjects including patient demographics, presenting symptoms, clinical signs, treatment received and treatment outcome were noted and analysed.

Result: The mean age of the patients was 45.1 years ± 14.9 years. Sixty-nine were males and 92.3% had bilateral involvement. The mean duration of onset of symptoms was 22.4 days ± 19.5. The most common presenting symptom was decreased vision (78.6%). Among the 13 patients 10 received intravenous acyclovir, 1 received intravenous ganciclovir and 2 patients received oral acyclovir for initial systemic therapy.

Conclusion: The most common complication was cataract followed by retinal detachment.

简介:急性视网膜坏死(ARN)是一种快速进展的坏死性疱疹性感染,通常导致视网膜脱离并伴有明显的视力病变。最常见的病原体属于疱疹病毒家族。它通常发生在健康的免疫能力强的个体。为了及时开始治疗,疾病的早期诊断非常重要。全身抗病毒药物和玻璃体内抗病毒药物治疗以及类固醇是治疗的主要手段。我们的研究是为期5年的回顾性研究。我们研究了尼泊尔三级保健中心急性视网膜坏死的患者人口统计学、表现特征、治疗结果和并发症。目的:方法:选取13例患者的14只眼作为研究对象。本研究是一项以医院为基础的回顾性研究,在三级眼科护理中心的葡萄膜炎和玻璃体视网膜科进行。本研究纳入了2013年5月至2018年5月期间诊断为急性视网膜坏死的所有患者的记录。记录并分析这些受试者的医院数据,包括患者人口统计学、表现症状、临床体征、接受的治疗和治疗结果。结果:患者平均年龄45.1岁±14.9岁。男性69例,92.3%双侧受累。平均发病时间为22.4天±19.5天。最常见的症状是视力下降(78.6%)。13例患者中10例接受静脉注射阿昔洛韦,1例接受更昔洛韦静脉注射,2例接受口服阿昔洛韦初始全身治疗。结论:白内障是最常见的并发症,其次为视网膜脱离。
{"title":"Clinical Profile and Treatment Outcomes of Acute Retinal Necrosis in a Tertiary Eye Care Centre in Nepal.","authors":"Priyanka Shrestha, Anu Manandhar","doi":"10.3126/nepjoph.v16i1.62167","DOIUrl":"10.3126/nepjoph.v16i1.62167","url":null,"abstract":"<p><strong>Introduction: </strong>Acute retinal necrosis (ARN) is a rapidly progressive, necrotizing herpetic infection, commonly leading to retinal detachment with significant visual morbidity. Most common causative agent belong to the herpesvirus family. It commonly occurs in healthy immunocompetent individuals. Early diagnosis of disease is important in order to start the treatment timely. Systemic antivirals and intravitreal antiviral therapy along with steroids are the main stay of treatment. Our study is a retrospective study of 5 years. We studied the patient demographics, presenting features, treatment outcome and complications of acute retinal necrosis in a tertiary care center in Nepal.</p><p><strong>Objective: </strong>Methodology: A total of 14 eyes of 13 patients were included in the study. This study is a hospital based retrospective study done in the Uveitis and Vitreoretinal department of a tertiary eye care center. Records of all patients diagnosed with Acute Retinal Necrosis between May 2013 to May 2018 were included in this study. Hospital data of these subjects including patient demographics, presenting symptoms, clinical signs, treatment received and treatment outcome were noted and analysed.</p><p><strong>Result: </strong>The mean age of the patients was 45.1 years ± 14.9 years. Sixty-nine were males and 92.3% had bilateral involvement. The mean duration of onset of symptoms was 22.4 days ± 19.5. The most common presenting symptom was decreased vision (78.6%). Among the 13 patients 10 received intravenous acyclovir, 1 received intravenous ganciclovir and 2 patients received oral acyclovir for initial systemic therapy.</p><p><strong>Conclusion: </strong>The most common complication was cataract followed by retinal detachment.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"44-52"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Oral Azithromycin Versus Doxycycline in Treatment of Meibomian Gland Dysfunction. 口服阿奇霉素与强力霉素治疗睑板腺功能障碍的疗效比较。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.46383
Ashesh Koirala, Samiksha Bhattarai, Sangeeta Shah, Bhuwan Govind Shrestha, Poonam Lavaju

Introduction: Meibomian gland dysfunction (MGD) is usually treated with conservative methods. Adjunct therapy with oral Doxycycline has played a vital role in its treatment. Recently Azithromycin has also been introduced as a newer agent.

Objective: To compare the efficacy, safety and compliance of oral azithromycin with doxycycline over one year period in patients with Meibomian gland dysfunction (MGD).

Methodology: A randomised comparative clinical trial was performed among 284 subjects (age >35 years) with MGD. They were randomly divided into two groups A and B. Along with standard conservative management, Group A received oral 9-day azithromycin (500 mg for 3 consecutive days for 3 consecutive weeks) and group B received 14 days doxycycline (200 mg/day). A score comprising seven symptoms and seven signs (primary outcome) was recorded before and at first and second follow up after treatment and further analyzed.

Result: The mean symptoms and signs treated by Azithromycin group was lesser as compared to Doxycycline group in the first follow up (p <0.001). However it was statistically insignificant at second follow-up (p=0.043). The group taking azithromycin had a much better overall response (p = 0.006). Gastrointestinal symptoms were the major side effects encountered, the group taking doxycycline experienced significantly more side effects (p ≤0.001).

Conclusion: Both antibiotics were effective and safe for treating persistent MGD, but azithromycin was more effective. It required a lower dose, worked faster, and had a shorter treatment duration compared to doxycycline.

简介:睑板腺功能障碍(MGD)通常采用保守方法治疗。口服强力霉素辅助治疗在其治疗中起着至关重要的作用。最近,阿奇霉素也作为一种较新的药物被引入。目的:比较口服阿奇霉素与强力霉素治疗眉板腺功能障碍(MGD)患者1年的疗效、安全性和依从性。方法:一项随机对照临床试验在284例MGD患者中进行(年龄0 ~ 35岁)。随机分为A、B两组。在标准保守治疗的基础上,A组患者口服阿奇霉素9天(500 mg,连续3天,连续3周),B组患者口服强力霉素14天(200 mg/天)。在治疗前和治疗后第一次和第二次随访时记录由7个症状和7个体征(主要结局)组成的评分,并进一步分析。结果:与多西环素组相比,阿奇霉素组第一次随访的平均症状和体征减轻(p)。结论:两种抗生素治疗持续性MGD均有效且安全,但阿奇霉素更有效。与强力霉素相比,它需要更低的剂量,起效更快,治疗持续时间更短。
{"title":"Efficacy of Oral Azithromycin Versus Doxycycline in Treatment of Meibomian Gland Dysfunction.","authors":"Ashesh Koirala, Samiksha Bhattarai, Sangeeta Shah, Bhuwan Govind Shrestha, Poonam Lavaju","doi":"10.3126/nepjoph.v16i1.46383","DOIUrl":"10.3126/nepjoph.v16i1.46383","url":null,"abstract":"<p><strong>Introduction: </strong>Meibomian gland dysfunction (MGD) is usually treated with conservative methods. Adjunct therapy with oral Doxycycline has played a vital role in its treatment. Recently Azithromycin has also been introduced as a newer agent.</p><p><strong>Objective: </strong>To compare the efficacy, safety and compliance of oral azithromycin with doxycycline over one year period in patients with Meibomian gland dysfunction (MGD).</p><p><strong>Methodology: </strong>A randomised comparative clinical trial was performed among 284 subjects (age >35 years) with MGD. They were randomly divided into two groups A and B. Along with standard conservative management, Group A received oral 9-day azithromycin (500 mg for 3 consecutive days for 3 consecutive weeks) and group B received 14 days doxycycline (200 mg/day). A score comprising seven symptoms and seven signs (primary outcome) was recorded before and at first and second follow up after treatment and further analyzed.</p><p><strong>Result: </strong>The mean symptoms and signs treated by Azithromycin group was lesser as compared to Doxycycline group in the first follow up (p <0.001). However it was statistically insignificant at second follow-up (p=0.043). The group taking azithromycin had a much better overall response (p = 0.006). Gastrointestinal symptoms were the major side effects encountered, the group taking doxycycline experienced significantly more side effects (p ≤0.001).</p><p><strong>Conclusion: </strong>Both antibiotics were effective and safe for treating persistent MGD, but azithromycin was more effective. It required a lower dose, worked faster, and had a shorter treatment duration compared to doxycycline.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"13-19"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pituitary Macroadenoma with Apoplexy, a Mimicker of Normal Tension Glaucoma (NTG): A Case Report. 垂体大腺瘤合并中风,模拟正常张力型青光眼1例。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.60134
Thinley, Keepa Vaidya, Sandip Tamang

Background: Asymmetric visual field defects with a high cup-to-disc ratio resembling glaucomatous damage can be the only clinical features of a pituitary macroadenoma with apoplexy, posing diagnostic challenges.

Case: A 39-year-old man presented with a history of gradual onset, progressive visual obscuration in the right visual field for one month without any other accompanying neurological symptoms. On examination, his intraocular pressure (IOP) was 16 mmHg in both eyes. Posterior segment examination revealed a cup to-disc ratio (CDR) of 0.8 in the right and 0.7 in the left eye, with concentric neuroretinal rim thinning and mild temporal disc pallor. These findings led to the diagnosis and treatment of normal tension glaucoma (NTG) elsewhere. Visual field examination showed field defects featuring a junctional scotoma. The MRI scan of the brain revealed a well-defined mass lesion situated in the sella suggestive of pituitary macroadenoma with possible apoplexy confirmed later through histopathological examination. The neurosurgery team successfully removed the tumor through the endoscopic endonasal trans-sphenoidal approach and the patient reported significant improvement in vision and visual field defects.

Observations: In our case, visual signs and symptoms were the only presenting features, caused by pituitary macroadenoma with apoplexy, which can be a potentially life-threatening condition. Although pituitary apoplexy is an acute condition with numerous neurological signs and symptoms, visual symptoms with high CDR and neuroretinal rim thinning with mild temporal disc pallor were the only features seen in our case, posing a diagnostic challenge. There were no associated systemic manifestations. However, the patient had a favorable outcome because of prompt diagnosis and multidisciplinary management.

Conclusion: The spectrum of clinical manifestations of pituitary macroadenoma with apoplexy should encompass a gradual onset, progressive asymmetric visual field defect with temporal disc pallor to facilitate timely diagnosis and effective management.

背景:类似青光眼损害的高杯盘比的不对称视野缺损可能是垂体大腺瘤合并中风的唯一临床特征,这给诊断带来了挑战。病例:一名39岁男性,右视野渐进性视力模糊1个月,无其他神经系统症状。经检查,他的双眼眼压(IOP)为16 mmHg。后节检查显示右眼杯盘比(CDR)为0.8,左眼为0.7,同心圆神经视网膜边缘变薄,轻度颞盘苍白。这些发现为其他地方的正常张力性青光眼(NTG)的诊断和治疗提供了依据。视野检查显示视野缺损,以交界暗点为特征。脑部核磁共振扫描显示位于鞍区一界限清楚的肿块,提示垂体大腺瘤,后经组织病理学检查证实可能为中风。神经外科团队通过鼻内窥镜经蝶窦入路成功切除肿瘤,患者报告视力和视野缺损有明显改善。观察:在我们的病例中,视觉体征和症状是唯一的表现特征,由垂体大腺瘤合并中风引起,这可能是一种潜在的危及生命的疾病。虽然垂体性中风是一种急性疾病,伴有许多神经系统体征和症状,但本病例仅表现为高CDR的视觉症状和神经视网膜边缘变薄及轻度颞盘苍白,这对诊断提出了挑战。没有相关的全身表现。然而,由于及时诊断和多学科治疗,患者预后良好。结论:垂体大腺瘤合并中风的临床表现应包括渐进性、渐进性视野不对称缺损伴颞盘苍白,便于及时诊断和有效治疗。
{"title":"Pituitary Macroadenoma with Apoplexy, a Mimicker of Normal Tension Glaucoma (NTG): A Case Report.","authors":"Thinley, Keepa Vaidya, Sandip Tamang","doi":"10.3126/nepjoph.v16i1.60134","DOIUrl":"10.3126/nepjoph.v16i1.60134","url":null,"abstract":"<p><strong>Background: </strong>Asymmetric visual field defects with a high cup-to-disc ratio resembling glaucomatous damage can be the only clinical features of a pituitary macroadenoma with apoplexy, posing diagnostic challenges.</p><p><strong>Case: </strong>A 39-year-old man presented with a history of gradual onset, progressive visual obscuration in the right visual field for one month without any other accompanying neurological symptoms. On examination, his intraocular pressure (IOP) was 16 mmHg in both eyes. Posterior segment examination revealed a cup to-disc ratio (CDR) of 0.8 in the right and 0.7 in the left eye, with concentric neuroretinal rim thinning and mild temporal disc pallor. These findings led to the diagnosis and treatment of normal tension glaucoma (NTG) elsewhere. Visual field examination showed field defects featuring a junctional scotoma. The MRI scan of the brain revealed a well-defined mass lesion situated in the sella suggestive of pituitary macroadenoma with possible apoplexy confirmed later through histopathological examination. The neurosurgery team successfully removed the tumor through the endoscopic endonasal trans-sphenoidal approach and the patient reported significant improvement in vision and visual field defects.</p><p><strong>Observations: </strong>In our case, visual signs and symptoms were the only presenting features, caused by pituitary macroadenoma with apoplexy, which can be a potentially life-threatening condition. Although pituitary apoplexy is an acute condition with numerous neurological signs and symptoms, visual symptoms with high CDR and neuroretinal rim thinning with mild temporal disc pallor were the only features seen in our case, posing a diagnostic challenge. There were no associated systemic manifestations. However, the patient had a favorable outcome because of prompt diagnosis and multidisciplinary management.</p><p><strong>Conclusion: </strong>The spectrum of clinical manifestations of pituitary macroadenoma with apoplexy should encompass a gradual onset, progressive asymmetric visual field defect with temporal disc pallor to facilitate timely diagnosis and effective management.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"80-86"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrence and Satisfaction in Patients after Pterygium Surgery in Tertiary Eye Hospital in Bhaktapur, Nepal. 尼泊尔巴克塔普尔第三眼科医院翼状胬肉手术患者的复发率和满意度
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.59388
Samata Sharma, Deepak Khadka, Arjun Shrestha, Nirsara Shrestha, Barsha Suwal, Bijay Khatri

Introduction: Pterygium is a common and benign condition that warrants surgical removal for ocular and cosmetic reasons. Pterygium excision with conjunctival autograft is frequently performed surgery in Nepal.

Objective: This study is aimed to find out the recurrence and satisfaction following surgery.

Methodology: This was a descriptive cross-sectional study conducted from August to October 2021 at a tertiary hospital in Bhaktapur. All the patients who had undergone pterygium surgery with conjunctival autograft surgery for primary pterygium from January 2018 to December 2019 and completed at least 6 months of follow-up were included. We reviewed records for surgery, complications, and recurrence from Medical Records. We also interviewed patients by phone for satisfaction related to symptomatic and cosmetic relief. The descriptive statistics were reported as frequency, mean, and standard deviation. The satisfaction score was measured on a 5-point Likert scale.

Result: Among 142 patients, the mean age was 46.70±11.25 years, and 28.17% were males. 7.74% had complications and graft edema was the most common. The recurrence rate after surgery was 5.63%. The recurrence was higher among males and under 40 years patients. More than one-third of the patients reported they had surgery for symptomatic relief. The study showed high satisfaction scores for both symptomatic relief and cosmetic appearance, with scores of 3.62±0.93 and 3.87±0.96, respectively, on a 5-point Likert scale.

Conclusion: Pterygium surgery with conjunctival autograft is safe surgery with minimal complications. Along with symptomatic relief, cosmetic satisfaction can be considered a measure of successful surgical outcome in pterygium surgery.

简介:翼状胬肉是一种常见的良性疾病,由于眼部和美容的原因,需要手术切除。翼状胬肉切除联合自体结膜移植是尼泊尔常见的手术。目的:了解术后复发情况及术后满意度。方法:这是一项描述性横断面研究,于2021年8月至10月在巴克塔普尔的一家三级医院进行。所有于2018年1月至2019年12月接受翼状胬肉手术并自体结膜移植手术治疗原发性翼状胬肉的患者,并完成至少6个月的随访。我们回顾了医疗记录中的手术、并发症和复发记录。我们还通过电话采访了患者对症状和美容缓解的满意度。描述性统计以频率、平均值和标准差报告。满意度是用5分李克特量表来衡量的。结果:142例患者平均年龄46.70±11.25岁,男性占28.17%。7.74%有并发症,以移植物水肿最为常见。术后复发率为5.63%。男性及40岁以下患者复发率较高。超过三分之一的患者报告说,他们通过手术来缓解症状。研究结果显示,患者在症状缓解和外观方面的满意度得分较高,在5分制的李克特量表上分别为3.62±0.93和3.87±0.96分。结论:翼状胬肉自体结膜移植手术安全,并发症少。随着症状的缓解,美容满意度可以被认为是衡量翼状胬肉手术成功的手术结果。
{"title":"Recurrence and Satisfaction in Patients after Pterygium Surgery in Tertiary Eye Hospital in Bhaktapur, Nepal.","authors":"Samata Sharma, Deepak Khadka, Arjun Shrestha, Nirsara Shrestha, Barsha Suwal, Bijay Khatri","doi":"10.3126/nepjoph.v16i1.59388","DOIUrl":"10.3126/nepjoph.v16i1.59388","url":null,"abstract":"<p><strong>Introduction: </strong>Pterygium is a common and benign condition that warrants surgical removal for ocular and cosmetic reasons. Pterygium excision with conjunctival autograft is frequently performed surgery in Nepal.</p><p><strong>Objective: </strong>This study is aimed to find out the recurrence and satisfaction following surgery.</p><p><strong>Methodology: </strong>This was a descriptive cross-sectional study conducted from August to October 2021 at a tertiary hospital in Bhaktapur. All the patients who had undergone pterygium surgery with conjunctival autograft surgery for primary pterygium from January 2018 to December 2019 and completed at least 6 months of follow-up were included. We reviewed records for surgery, complications, and recurrence from Medical Records. We also interviewed patients by phone for satisfaction related to symptomatic and cosmetic relief. The descriptive statistics were reported as frequency, mean, and standard deviation. The satisfaction score was measured on a 5-point Likert scale.</p><p><strong>Result: </strong>Among 142 patients, the mean age was 46.70±11.25 years, and 28.17% were males. 7.74% had complications and graft edema was the most common. The recurrence rate after surgery was 5.63%. The recurrence was higher among males and under 40 years patients. More than one-third of the patients reported they had surgery for symptomatic relief. The study showed high satisfaction scores for both symptomatic relief and cosmetic appearance, with scores of 3.62±0.93 and 3.87±0.96, respectively, on a 5-point Likert scale.</p><p><strong>Conclusion: </strong>Pterygium surgery with conjunctival autograft is safe surgery with minimal complications. Along with symptomatic relief, cosmetic satisfaction can be considered a measure of successful surgical outcome in pterygium surgery.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"53-61"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Scenario of Pseudomyopia Before and After Vision Therapy: Two Case Reports. 视力治疗前后假性近视的临床情况:2例报告。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.59178
Santosh Chhetri, Suraj Thapa Magar, Srijana Adhikari, Umesh Belbase

Introduction: Cycloplegic agents are the most common method used for accommodation relaxation in accommodative spasm cases. However, concerns have arisen about the possibility of rebound effects following the cessation of cycloplegic treatment. This case reports demonstrates a clinical approach for managing accommodative spasm, utilizing the modified Borish's delayed subjective technique and vision therapy. Additionally, also evaluates the patient's clinical status after six months of cessation of therapy. Case Report 1: A 9-year-old female presented with a headache and blurred vision. Her presenting visual acuity was 1/60 in each eye and variable myopia reached up to -6.00 diopters spherical. Cycloplegic refraction showed a low hyperopia and improvement in visual acuity to 6/9 in each eye. This confirmed the diagnosis as accommodative spasm and was referred to a vision therapy clinic for further management. Case Report 2: A 13-year-old female presented with 6/36 visual acuity in both eyes and variable myopic refractive error but cycloplegic refraction revealed low hyperopia and improvement in visual acuity. Then, she was referred to optometry and vision therapy clinic.

Conclusion: A modified Borish's delay subjective technique can be applied to instantaneous relief of accommodative spasm. Vision therapy can be useful in restoring normal accommodative and vergence functions. Sustained improvement in visual function and stability of accommodation is obtained after six months of cessation of vision therapy.

简介:在适应性痉挛病例中,最常用的方法是使用麻痹剂进行适应性放松。然而,人们担心停止治疗后可能出现反弹效应。本病例报告展示了一种管理适应性痉挛的临床方法,利用改进的Borish延迟主观技术和视觉治疗。此外,还评估患者停止治疗六个月后的临床状态。病例报告1:一名9岁女童,表现为头痛和视力模糊。她的表现视力为每只眼睛1/60,可变近视达到-6.00屈光度球面。单眼麻痹性屈光表现为低度远视,每只眼视力改善至6/9。这证实了诊断为适应性痉挛,并被转介到视力治疗诊所进行进一步治疗。病例报告2:一名13岁女性,双眼视力6/36,变异性近视屈光不正,但睫状体麻痹性屈光显示低远视,视力改善。然后,她被转介到验光和视力治疗诊所。结论:改进的Borish延迟主观技术可用于调节性痉挛的瞬时缓解。视力治疗可用于恢复正常的调节和收敛功能。停止视力治疗6个月后,视力功能和调节稳定性得到持续改善。
{"title":"Clinical Scenario of Pseudomyopia Before and After Vision Therapy: Two Case Reports.","authors":"Santosh Chhetri, Suraj Thapa Magar, Srijana Adhikari, Umesh Belbase","doi":"10.3126/nepjoph.v16i1.59178","DOIUrl":"10.3126/nepjoph.v16i1.59178","url":null,"abstract":"<p><strong>Introduction: </strong>Cycloplegic agents are the most common method used for accommodation relaxation in accommodative spasm cases. However, concerns have arisen about the possibility of rebound effects following the cessation of cycloplegic treatment. This case reports demonstrates a clinical approach for managing accommodative spasm, utilizing the modified Borish's delayed subjective technique and vision therapy. Additionally, also evaluates the patient's clinical status after six months of cessation of therapy. Case Report 1: A 9-year-old female presented with a headache and blurred vision. Her presenting visual acuity was 1/60 in each eye and variable myopia reached up to -6.00 diopters spherical. Cycloplegic refraction showed a low hyperopia and improvement in visual acuity to 6/9 in each eye. This confirmed the diagnosis as accommodative spasm and was referred to a vision therapy clinic for further management. Case Report 2: A 13-year-old female presented with 6/36 visual acuity in both eyes and variable myopic refractive error but cycloplegic refraction revealed low hyperopia and improvement in visual acuity. Then, she was referred to optometry and vision therapy clinic.</p><p><strong>Conclusion: </strong>A modified Borish's delay subjective technique can be applied to instantaneous relief of accommodative spasm. Vision therapy can be useful in restoring normal accommodative and vergence functions. Sustained improvement in visual function and stability of accommodation is obtained after six months of cessation of vision therapy.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"74-79"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of Horizontal Strabismus Surgery and Factors Influencing Surgical Success. 水平斜视手术疗效及影响手术成功的因素。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.50291
Rojeeta Parajuli, Srijana Adhikari, Manish Poudel, Hening Naluria, Radhika Upreti Oli, Pradeep Banjara

Introduction: Strabismus is a complex problem of eye alignment, binocularity, and cosmetics that affect vision and quality of life. Strabismus surgery helps to establish binocular fusion, expand the field of binocular vision, eliminate diplopia, correct a compensatory head posture, and improve cosmetic appearance. The outcomes of horizontal strabismus surgery range from 56.3-86.5%. It depends on different factors such as the type of strabismus, accurate measurement of pre-operative deviation, age at which strabismus surgery was performed for the first time, type of strabismus surgery, postoperative alignment, and binocularity. Regrettably, there is insufficient data regarding the prevalence of strabismus and the outcomes of surgical interventions in Nepal. This study addresses the outcome of strabismus surgery and the factors influencing surgical success conducted at a tertiary hospital.

Objective: To evaluate the outcome of horizontal strabismus surgery and factors influencing surgical success.

Methodology: The medical records of 206 patients who had undergone their first horizontal strabismus surgery at Tilganga Institute of Ophthalmology (TIO) from 2017 to 2020 were reviewed retrospectively. Those who completed a follow-up period for at least 3 months were included. Patients with restrictive, paralytic, and vertical strabismus were excluded from the study. The success of the surgery was defined by achieving an eye deviation of less than 10 prism diopters (PD) six weeks post-surgery. The influencing factors for surgical success (diagnosis, age group, visual acuity, binocular function, and pre-operative angle of deviations) were analyzed.

Result: Complete data of 194 patients with follow-up periods of 6 weeks to 3 months were retrieved from the electronic medical record. The majority 116(59.8%) of the patients were between 6-18 years >18-53years 40.2% (78) with male to female ratio of 0.96:1. Majority of the participants had exotropia 124(63.9%) and mean pre-operative angle of deviation was 48.9±14.7PD (Range 10- 90). A good motor alignment (total success rate) was 44.3 %( 86); the success rate for esotropia was 36(41.9%) and for exotropia was 50(58.1%). Both fusion and stereopsis were significantly improved after surgery (P<0.001). The patient who had a smaller deviation in the preoperative period had good surgical success in the postoperative period.(P <0.001). The type of deviation, age, gender, pre-operative amblyopia, and binocular vision were not related to the surgical success.

Conclusion: In cases of horizontal concomitant strabismus, the preoperative amount of deviation is the paramount factor influencing surgical success. Notably, surgical success is low in patients with large preoperative deviation.

斜视是一个复杂的问题,眼睛对准,双眼视,化妆品,影响视力和生活质量。斜视手术有助于建立双眼融合,扩大双眼视野,消除复视,纠正补偿性头姿,改善美观。水平斜视手术的结果在56.3-86.5%之间。这取决于不同的因素,如斜视类型、术前偏差的准确测量、第一次斜视手术的年龄、斜视手术类型、术后对准和双眼。遗憾的是,关于尼泊尔斜视患病率和手术干预结果的数据不足。本研究探讨在三级医院进行斜视手术的结果及影响手术成功的因素。目的:探讨水平斜视手术治疗效果及影响手术成功的因素。方法:回顾性分析2017 - 2020年在蒂尔甘加眼科研究所(TIO)首次行水平斜视手术的206例患者的病历。那些完成了至少3个月随访期的人被包括在内。限制性斜视、麻痹性斜视和垂直斜视患者被排除在研究之外。手术成功的标准是术后6周眼偏差小于10棱镜屈光度(PD)。分析影响手术成功的因素(诊断、年龄、视力、双眼功能、术前偏移角度)。结果:从电子病历中检索到194例患者的完整资料,随访时间为6周~ 3个月。6 ~ 18岁116例(59.8%),18 ~ 53岁78例(40.2%),男女比例为0.96:1。大多数参与者有外斜视124(63.9%),平均术前偏斜角为48.9±14.7PD(范围10- 90)。良好的电机对准(总成功率)为44.3% (86);内斜视的成功率为36(41.9%),外斜视的成功率为50(58.1%)。结论:对于水平伴发性斜视,术前偏斜度是影响手术成功的最重要因素。值得注意的是,术前偏差较大的患者手术成功率较低。
{"title":"Outcome of Horizontal Strabismus Surgery and Factors Influencing Surgical Success.","authors":"Rojeeta Parajuli, Srijana Adhikari, Manish Poudel, Hening Naluria, Radhika Upreti Oli, Pradeep Banjara","doi":"10.3126/nepjoph.v16i1.50291","DOIUrl":"10.3126/nepjoph.v16i1.50291","url":null,"abstract":"<p><strong>Introduction: </strong>Strabismus is a complex problem of eye alignment, binocularity, and cosmetics that affect vision and quality of life. Strabismus surgery helps to establish binocular fusion, expand the field of binocular vision, eliminate diplopia, correct a compensatory head posture, and improve cosmetic appearance. The outcomes of horizontal strabismus surgery range from 56.3-86.5%. It depends on different factors such as the type of strabismus, accurate measurement of pre-operative deviation, age at which strabismus surgery was performed for the first time, type of strabismus surgery, postoperative alignment, and binocularity. Regrettably, there is insufficient data regarding the prevalence of strabismus and the outcomes of surgical interventions in Nepal. This study addresses the outcome of strabismus surgery and the factors influencing surgical success conducted at a tertiary hospital.</p><p><strong>Objective: </strong>To evaluate the outcome of horizontal strabismus surgery and factors influencing surgical success.</p><p><strong>Methodology: </strong>The medical records of 206 patients who had undergone their first horizontal strabismus surgery at Tilganga Institute of Ophthalmology (TIO) from 2017 to 2020 were reviewed retrospectively. Those who completed a follow-up period for at least 3 months were included. Patients with restrictive, paralytic, and vertical strabismus were excluded from the study. The success of the surgery was defined by achieving an eye deviation of less than 10 prism diopters (PD) six weeks post-surgery. The influencing factors for surgical success (diagnosis, age group, visual acuity, binocular function, and pre-operative angle of deviations) were analyzed.</p><p><strong>Result: </strong>Complete data of 194 patients with follow-up periods of 6 weeks to 3 months were retrieved from the electronic medical record. The majority 116(59.8%) of the patients were between 6-18 years >18-53years 40.2% (78) with male to female ratio of 0.96:1. Majority of the participants had exotropia 124(63.9%) and mean pre-operative angle of deviation was 48.9±14.7PD (Range 10- 90). A good motor alignment (total success rate) was 44.3 %( 86); the success rate for esotropia was 36(41.9%) and for exotropia was 50(58.1%). Both fusion and stereopsis were significantly improved after surgery (P<0.001). The patient who had a smaller deviation in the preoperative period had good surgical success in the postoperative period.(P <0.001). The type of deviation, age, gender, pre-operative amblyopia, and binocular vision were not related to the surgical success.</p><p><strong>Conclusion: </strong>In cases of horizontal concomitant strabismus, the preoperative amount of deviation is the paramount factor influencing surgical success. Notably, surgical success is low in patients with large preoperative deviation.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"5-12"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report of Orbital Venolymphatic Malformation - A diagnostic dilemma. 眼眶静脉淋巴畸形1例报告-诊断困境。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.59775
Priyanka Sunda, Ankita Jakhar, Shaheen Farooq, Shweta, Mohnish Bothra, Anju Kochar

Introduction: Intermittent proptosis is a transitory position-dependent protrusion of one or both eyeballs beyond orbit. The common causes of proptosis in young females are tumors, inflammation, trauma, thyroid eye disease and vascular lesions. The case report highlights the importance of imaging in prone position.

Case: We report a rare case of a 24-year-old female who recently developed intermittent proptosis while bending forwards. The patient was evaluated clinically. Ultrasonography B scan, Computerised axial tomography (CT), Magnetic resonance imaging (MRI) were advised to rule out orbital varices, arteriovenous aneurysm, or any organic lesion. Probable diagnosis of venolymphatic malformation was made.

Conclusion: An intertwined approach was carried out with Ophthalmologist and Radiologist to arrive at the final diagnosis highlighting the importance of imaging in prone position.

简介:间歇性眼球突出是一个或两个眼球的短暂的位置依赖突出超出眼眶。年轻女性眼球突出的常见原因是肿瘤、炎症、创伤、甲状腺眼病和血管病变。该病例报告强调了俯卧位成像的重要性。病例:我们报告一个罕见的病例24岁的女性谁最近发展间歇突出,而向前弯曲。对患者进行临床评估。B超、计算机轴位断层扫描(CT)、磁共振成像(MRI)建议排除眼眶静脉曲张、动静脉动脉瘤或任何有机病变。可能的诊断为静脉淋巴畸形。结论:眼科医生和放射科医生进行了交叉检查,得出了最终诊断,强调了俯卧位成像的重要性。
{"title":"A Case Report of Orbital Venolymphatic Malformation - A diagnostic dilemma.","authors":"Priyanka Sunda, Ankita Jakhar, Shaheen Farooq, Shweta, Mohnish Bothra, Anju Kochar","doi":"10.3126/nepjoph.v16i1.59775","DOIUrl":"10.3126/nepjoph.v16i1.59775","url":null,"abstract":"<p><strong>Introduction: </strong>Intermittent proptosis is a transitory position-dependent protrusion of one or both eyeballs beyond orbit. The common causes of proptosis in young females are tumors, inflammation, trauma, thyroid eye disease and vascular lesions. The case report highlights the importance of imaging in prone position.</p><p><strong>Case: </strong>We report a rare case of a 24-year-old female who recently developed intermittent proptosis while bending forwards. The patient was evaluated clinically. Ultrasonography B scan, Computerised axial tomography (CT), Magnetic resonance imaging (MRI) were advised to rule out orbital varices, arteriovenous aneurysm, or any organic lesion. Probable diagnosis of venolymphatic malformation was made.</p><p><strong>Conclusion: </strong>An intertwined approach was carried out with Ophthalmologist and Radiologist to arrive at the final diagnosis highlighting the importance of imaging in prone position.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"103-107"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic Biomarkers Predictive of Anatomical and Functional Outcomes of Macular Edema Secondary to Retinal Vein Occlusion Following a Single Injection of Intravitreal Bevacizumab. 单次玻璃体内注射贝伐单抗后继发于视网膜静脉闭塞的黄斑水肿的解剖和功能结局的系统性生物标志物预测。
IF 0.2 Q4 OPHTHALMOLOGY Pub Date : 2024-01-01 DOI: 10.3126/nepjoph.v16i1.58649
Shivraj Tagare, Manavi D Sindal

Introduction: Macular edema (ME) secondary to retinal vein occlusion (RVO) is a leading cause for visual impairment.

Objective: To identify the systemic biomarkers that influence the anatomical and functional outcomes of a single injection of intravitreal bevacizumab (IVB) for RVO related macular edema ME.

Methodology: A prospective interventional study was conducted on patients with treatment naïve RVO induced ME, from November 2019 to April 2021 after ethical approval. All participants underwent a complete systemic evaluation consisting of blood pressure measurement, blood sugar, glycosylated hemoglobin, hemoglobin, total and differential cell counts, lipid profile and renal function tests at baseline. IVB was administered for RVO induced ME. Anatomical outcome was measured as change in macular thickness from baseline to one month after treatment on optical coherence tomography and functional outcomes were improvement in visual acuity.

Result: Median best corrected visual acuity improved from 0.56±0.39 to 0.4±0.4 LogMAR (p <0.001) with significant reduction in mean central retina thickness (CRT) from 609.9±216.5 μ to 337.6±168.2 μ (p <0.001) at one month. On evaluating systemic parameters, longer duration of hypertension (r = -0.2795, p = 0.037), and those with higher eosinophil count (r = -0.2595, p = 0.025) were less likely to have a reduction in CRT. Higher HDL levels (r = 0.2505, p = 0.031) and better RBC counts (r = 0.2732, p = 0.016) were more likely to be predictive of a better reduction of CRT.

Conclusion: Patients with RVO related ME can experience visual improvement and reduction in edema at initiation of treatment. Systemic biomarkers correlating to those for cardiovascular morbidity influence outcomes of ME. Optimum management of these modifiable systemic biomarkers can enhance treatment outcomes.

黄斑水肿(ME)继发于视网膜静脉阻塞(RVO)是视力损害的主要原因。目的:确定影响单次玻璃体内注射贝伐单抗(IVB)治疗RVO相关性黄斑水肿ME的解剖和功能结果的系统生物标志物。方法:经伦理批准,于2019年11月至2021年4月对治疗naïve RVO诱导ME的患者进行前瞻性介入研究。所有参与者在基线时进行了完整的系统评估,包括血压测量、血糖、糖化血红蛋白、血红蛋白、总细胞计数和差异细胞计数、脂质谱和肾功能测试。对RVO诱导的ME给予静脉注射。解剖结果是通过光学相干断层扫描测量黄斑厚度从基线到治疗后一个月的变化,功能结果是视力的改善。结果:中位最佳矫正视力从0.56±0.39提高到0.4±0.4 LogMAR (p)。结论:RVO相关性ME患者在治疗开始时视力得到改善,水肿减少。与心血管疾病相关的系统生物标志物影响ME的预后。这些可修改的系统生物标志物的最佳管理可以提高治疗效果。
{"title":"Systemic Biomarkers Predictive of Anatomical and Functional Outcomes of Macular Edema Secondary to Retinal Vein Occlusion Following a Single Injection of Intravitreal Bevacizumab.","authors":"Shivraj Tagare, Manavi D Sindal","doi":"10.3126/nepjoph.v16i1.58649","DOIUrl":"10.3126/nepjoph.v16i1.58649","url":null,"abstract":"<p><strong>Introduction: </strong>Macular edema (ME) secondary to retinal vein occlusion (RVO) is a leading cause for visual impairment.</p><p><strong>Objective: </strong>To identify the systemic biomarkers that influence the anatomical and functional outcomes of a single injection of intravitreal bevacizumab (IVB) for RVO related macular edema ME.</p><p><strong>Methodology: </strong>A prospective interventional study was conducted on patients with treatment naïve RVO induced ME, from November 2019 to April 2021 after ethical approval. All participants underwent a complete systemic evaluation consisting of blood pressure measurement, blood sugar, glycosylated hemoglobin, hemoglobin, total and differential cell counts, lipid profile and renal function tests at baseline. IVB was administered for RVO induced ME. Anatomical outcome was measured as change in macular thickness from baseline to one month after treatment on optical coherence tomography and functional outcomes were improvement in visual acuity.</p><p><strong>Result: </strong>Median best corrected visual acuity improved from 0.56±0.39 to 0.4±0.4 LogMAR (p <0.001) with significant reduction in mean central retina thickness (CRT) from 609.9±216.5 μ to 337.6±168.2 μ (p <0.001) at one month. On evaluating systemic parameters, longer duration of hypertension (r = -0.2795, p = 0.037), and those with higher eosinophil count (r = -0.2595, p = 0.025) were less likely to have a reduction in CRT. Higher HDL levels (r = 0.2505, p = 0.031) and better RBC counts (r = 0.2732, p = 0.016) were more likely to be predictive of a better reduction of CRT.</p><p><strong>Conclusion: </strong>Patients with RVO related ME can experience visual improvement and reduction in edema at initiation of treatment. Systemic biomarkers correlating to those for cardiovascular morbidity influence outcomes of ME. Optimum management of these modifiable systemic biomarkers can enhance treatment outcomes.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":"16 31","pages":"31-43"},"PeriodicalIF":0.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nepalese Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1